Clinical Trial Update: A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the safety (compared to iron sucrose), efficacy, and pharmacokinetics of Ferumoxytol for iron deficiency anemia in pediatric…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Iron Deficiency Anemia

Drugs mentioned

• FERUMOXYTOL (ferumoxytol)

Snippet

Sponsor: AMAG Pharmaceuticals, Inc. | Conditions: Chronic Kidney Disease; Iron Deficiency Anemia | Phase 3 | Status: RECRUITING